← Product Code [DYB](/submissions/CV/subpart-b%E2%80%94cardiovascular-diagnostic-devices/DYB) · K030905 # MEDAMICUS FLOWGUARD PEELABLE INTRODUCER (K030905) _Medamicus, Inc. · DYB · Apr 9, 2003 · Cardiovascular · SESE_ **Canonical URL:** https://fda.innolitics.com/submissions/CV/subpart-b%E2%80%94cardiovascular-diagnostic-devices/DYB/K030905 ## Device Facts - **Applicant:** Medamicus, Inc. - **Product Code:** [DYB](/submissions/CV/subpart-b%E2%80%94cardiovascular-diagnostic-devices/DYB.md) - **Decision Date:** Apr 9, 2003 - **Decision:** SESE - **Submission Type:** Special - **Regulation:** 21 CFR 870.1340 - **Device Class:** Class 2 - **Review Panel:** Cardiovascular ## Indications for Use The MedAmics FlowGuard™ Peelable Introducer is indicated for use in the percutaneous insertion of pacing leads or catheters in the venous system. ## Device Story FlowGuard™ Peelable Introducer is a small-diameter tubular device with proximal handles; facilitates atraumatic implantation of catheters and pacemaker leads into venous system. Features 'tear-away' design allowing introducer removal while leaving inserted catheter or lead in place. Used by clinicians in clinical settings. Packaged as convenience kits (with needle, syringe, guidewire), individually pouched sterile units, or bulk non-sterile units. Device provides mechanical access to venous system; no electronic or software components. ## Clinical Evidence No clinical data. Bench testing only; packaging validation performed via risk analysis comparing new configurations to previously approved convenience kit packaging. ## Technological Characteristics Small-diameter tubular introducer with proximal handles; 'tear-away' mechanism. No changes to device design. Packaging validation compliant with EN1441:1998. ## Regulatory Identification A catheter introducer is a sheath used to facilitate placing a catheter through the skin into a vein or artery. ## Predicate Devices - MedAmicus Valved Peelable Introducer ([K021004](/device/K021004.md)) ## Submission Summary (Full Text) > This content was OCRed from public FDA records by [Innolitics](https://innolitics.com). If you use, quote, summarize, crawl, or train on this content, cite Innolitics at https://innolitics.com. > > Innolitics is a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices, including [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/). {0}------------------------------------------------ MedAmicus, Inc. Confidential #### 510(k) Summary V. #### Submitter APR - 9 2003 MedAmicus, Incorporated 15301 Highway 55 West Minneapolis, MN 55447 Main: 763-15301 763-559-0148 Fax: email: www.medamicus.com Date Prepared March 20, 2003 Trade Name MedAmicus FlowGuard™ Peelable Introducer # Common Name Catheter Introducer Predicate Device MedAmicus Valved Peelable Introducer K021004 # Device Description The MedAnicus FlowGuard™ Peelable Introducer is a small diameter tubular shaped device with integrated proximal handles. The FlowGuard™ Peelable Introducer is designed to provide a relatively atraumatic method for implanting catheters and pacemaker leads into the venous system. The FlowGuard™ Peelable Introducer has a "teat-away" feature common to the predicate devices. This feature allows the user to remove the introducer without removing the inserted catheter or pacing lead. The MedAmicus FlowGuard™ Peelable Introducer is packaged in three configurations: 1) a convenience kit containing a MedAmicus FlowGuard 100 Peelable Introducer, a thin-wall needle, a disposable syringe, and a flexible guidewire, packaged in a tray and a sealed pouch. 2) individually pouched, sterile MedAmicus FlowGuard™ Peelable Introducer and 3) bulk, nonsterile MedAmicus FlowGuard™ Peelable Introducers. {1}------------------------------------------------ # Intended Use There are no changes to the Intended Use of the device from the currently approved device. The MedAmics FlowGuard™ Peelable Introducer is indicated for use in the percutaneous insertion of pacing leads or catheters in the venous system. ### Technological Characteristics The modified packaging of this device is technologically equivalent to the currently approved device. ## Summary of Studies Design Verification of the device is not required as there are no design modifications to the device. A packaging validation will be completed for the individually pouched, sterile introducers to ensure that there is no effect on the safety and effectiveness of the device. This validation will be completed based on a Risk Analysis per internal procedures that are compliant with European Standard EN1441: 1998 Medical Devices - Risk Analysis. This Risk Analysis was completed by comparing the risks associated with the new packaging configurations with the currently approved convenience kit packaging. This validation is summarized in Section X of this submission. {2}------------------------------------------------ Image /page/2/Picture/1 description: The image is a black and white logo for the U.S. Department of Health & Human Services. The logo features a circular design with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around the perimeter. Inside the circle is a stylized symbol consisting of three abstract human profiles facing to the right, stacked on top of each other. Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850 APR - 9 2003 Mr. Karyl Haskell Quality Assuarance and Regulatory Affairs Manager MedAmicus, Incorporated 15301 Highway 55 West Minneapolis, MN 55447 K030905 Re: Trade/Device Name: MedAmicus FlowGuard™ Peelable Introducer Regulation Number: 21 CFR 870.1340 Regulation Name: Catheter introducer. Regulatory Class: Class II Product Code: DYB Dated: March 21, 2003 Received: March 24, 2003 Dear Mr. Haskell: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set {3}------------------------------------------------ Page 2 - Mr. Karyl Haskell forth in the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (301) 594-4646. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97) you may obtain. Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html Sincerely yours, KOBATU Gram D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {4}------------------------------------------------ MedAmicus, Inc. Confidential #### Indications for Use VI. 510(k) Number (if known): Not Assigned Device Name: MedAmicus FlowGuard™ Peelable Introducer Indications for Use: The MedAmicus FlowGuard™ Peelable Introducer indicated for use in the percutaneous insertion of pacing leads or catheters in the venous system. (PLEASE DO NOT WRITE BELOW THIS LINE -- CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE) Prescription Use X OR Over-The-Counter Use (Per 21 CFR 801.109) (Division Sign-Off) Division of Cardiovascular Devices 510(k) Number K030965 --- **Source:** [https://fda.innolitics.com/submissions/CV/subpart-b%E2%80%94cardiovascular-diagnostic-devices/DYB/K030905](https://fda.innolitics.com/submissions/CV/subpart-b%E2%80%94cardiovascular-diagnostic-devices/DYB/K030905) **Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact). **Cite:** Innolitics at https://innolitics.com